Tavčar, L.B.; Lučovnik, M.; Hrobat, H.; Gornik, L.; Preložnik Zupan, I.
Risk of Hypophosphatemia Following Postpartum Anemia Treatment with IV Ferric Carboxymaltose, IV Ferric Derisomaltose, and Oral Ferrous Sulfate. J. Clin. Med. 2025, 14, 8393.
https://doi.org/10.3390/jcm14238393
AMA Style
Tavčar LB, Lučovnik M, Hrobat H, Gornik L, Preložnik Zupan I.
Risk of Hypophosphatemia Following Postpartum Anemia Treatment with IV Ferric Carboxymaltose, IV Ferric Derisomaltose, and Oral Ferrous Sulfate. Journal of Clinical Medicine. 2025; 14(23):8393.
https://doi.org/10.3390/jcm14238393
Chicago/Turabian Style
Tavčar, Lea Bombač, Miha Lučovnik, Hana Hrobat, Lea Gornik, and Irena Preložnik Zupan.
2025. "Risk of Hypophosphatemia Following Postpartum Anemia Treatment with IV Ferric Carboxymaltose, IV Ferric Derisomaltose, and Oral Ferrous Sulfate" Journal of Clinical Medicine 14, no. 23: 8393.
https://doi.org/10.3390/jcm14238393
APA Style
Tavčar, L. B., Lučovnik, M., Hrobat, H., Gornik, L., & Preložnik Zupan, I.
(2025). Risk of Hypophosphatemia Following Postpartum Anemia Treatment with IV Ferric Carboxymaltose, IV Ferric Derisomaltose, and Oral Ferrous Sulfate. Journal of Clinical Medicine, 14(23), 8393.
https://doi.org/10.3390/jcm14238393